Arthur S. Kirsch

Insider Reports History

Identity 1 identity field
Location
Mississauga
SEC source record 1 source field
Owner filing signature
/s/ Gregory S. Moss, Attorney-in-Fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Arthur S. Kirsch

Form 4 holding Director

Liquidia Corp

Security class
Common Stock
Shares / value
30,000
Estimated value
$450,000
Report date
17 Jun 2025
Price
$15.00
Ownership
Through Revocable Trust of Arthur S. Kirsch
Form 4 holding Director

Atea Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
164,800
Estimated value
Report date
20 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Evommune, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
37,960
Estimated value
Report date
05 Nov 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kadmon Holdings, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
09 Nov 2021
Price
$9.50
Ownership
Direct
Form 4 holding Director

Kadmon Holdings, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
09 Nov 2021
Price
$5.54
Ownership
Direct
Underlying class
Common Stock, par value $0.001
Underlying amount

Insider Reports Filed by Arthur S. Kirsch

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .